Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine Hydrochloride for Hypertension
NCT04790942Phase 4Unknown
- Start
- Oct 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of berberine in essential hypertension and endothelial dysfunction (2 arms). Primary endpoints: Office blood pressure at 3 months and brachial-ankle pulse wave velocity at 3 months. Status: unknown.
02
Drugs
berberine
03
Conditions
essential hypertensionendothelial dysfunction
Beyond the preview
Go deeper on NCT04790942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04790942.